e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Successful targeted therapy of advanced lung cancer
F. Gamarra (Munich, Germany)
Source:
Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session
Session:
Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session
Session type:
Grand round
Number:
3462
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Gamarra (Munich, Germany). Successful targeted therapy of advanced lung cancer. Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Michele Gallo - 12.10.2013 09:08
Important contribution
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Targeted therapy for lung cancer
Source: Eur Respir J 2015; 46: 1239-1241
Year: 2015
Advances in target therapy for lung cancer
Source: International Congress 2014 – Ceremony for the ERS Romain Pauwels Research Award 2014 - Clinical Year in Review I
Year: 2014
Advances in target therapy in lung cancer
Source: Eur Respir Rev 2015; 24: 23-29
Year: 2015
Current neoadjuvant/adjuvant treatment for advanced stage lung cancer
Source: International Congress 2014 – PG19 Surgery for advanced stage lung cancer
Year: 2014
Possibilities of palliative combined therapy for extensive nonsmall cells lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 378s
Year: 2001
Modern profiling of advanced lung cancer at the primary diagnosis and during therapy
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018
Effectiveness of chemotherapy for advanced lung cancer in the elderly
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009
Second-line therapy in elderly patients with advanced nonsmall cell lung cancer
Source: Eur Respir J 2014; 43: 240-249
Year: 2004
A preliminary study on targeted therapies in advanced lung cancer patients
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009
Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer
Source: Eur Respir J 2013; 42: 1119-1133
Year: 2013
Targeted therapy in non-small cell lung cancer
Source: Breathe 2012; 8: 206-215
Year: 2012
Surgical treatment of nonsmall cell lung cancer
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=170
Year: 2001
Mianserin therapy in advanced lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 367s
Year: 2002
Use of 2
nd
-line polychemotherapy in advanced nonsmall cell lung cancer – a reasonable approach
Source: Eur Respir J 2003; 22: Suppl. 45, 65s
Year: 2003
Prevalence and effectiveness of third-line therapy for advanced non-small cell lung cancer (A-NSCLC)
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
The method of individualisation of treatment and prognosis for advanced non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
Nonsurgical treatment of recurrent lung cancer
Source: Annual Congress 2007 - Recurrence of lung cancer following resection with curative intent
Year: 2007
Iodine-125 seed brachytherapy combined with pembrolizumab for advanced non-small-cell lung cancer after failure of first-line chemotherapy.
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021
Novel approaches in metastasised non-small cell lung cancer with a special focus on modern systemic therapies
Source: International Congress 2019 – State of the art session: Thoracic oncology
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept